Views: 0 Author: Sayt Ɛditɔ Pɔblish Taym: 2025-07-24 Ɔrijin: Ples
Frɔm Julay 16 to 18, di Malezya Intanɛshɔnal Tred ɛn Ɛgzibishin Sɛnta (MITEC) na Kuala Lumpur bin gɛt Medlab Eshya & Eshya Wɛlbɔdi 2025, we na di big wan we gɛt IVD ɛn laboratori ikwipmɛnt ɛgzibishin na di ASEAN rijɔn.
Globɛl Patisipeshɔn: 500+ ɛntapraiz dɛm frɔm 54 kɔntri dɛm, inklud industri jayant dɛm lɛk Roche ɛn Siemens, ɛn Chaynish inovatɔ dɛm lɛk Hotgen Biotech.
Ɔdiɛns Rich: 10,000+ pɔshɔnal atɛndans, wit 40% frɔm Tayland, 20% frɔm Malezya, ɛn 19% frɔm Indonishia.
Maket Potɛnshɔnal: Na stratejik pletfɔm fɔ tap insay di $740 bilyan ASEAN wɛlbɔdi makɛt, fɔ fos teknɔlɔji ɛkshɛnj ɛn patnaship.
As lida na Chaina in ɔtpidik divays sɛktɔ, CZMEDITECH mak in fɔs apia na Medlab Eshia 2025, we i lanch in '2025 Global Inovation Tour' ɛn sho injinɛri ɛksɛlɛns to di intanashɔnal mɛdikal kɔmyuniti.
Brij fɔ Kɔlabɔreshɔn: Dɛn dɔn mek kɔnekshɔn wit di glob ɔl wɛlbɔdi biznɛs pipul dɛn fɔ di kɔt-ɛj ɔtpidik tɛknɔlɔji ɛkshɛnj.
Brand Visibility: Ɛnhans rɛkɔgnishɔn na Sawt Is Eshia, wan impɔtant growth makɛt fɔ mɛdikal divays.
CZMEDITECH atrak signifyant atɛnshɔn wit in 5 flagship prodak dɛm, we dɛn ɔptimayz fɔ klinik kɔvinɛns ɛn ɔspitul efyushɔn:
Uni-C Standalɔn Sɛvikal Kej
Posterior sεvikal skru sistεm (Nyu) .
Anterior sεvikal spayna fiksεshכn sistεm
Ekspɛkt Fibular Intramɛdulari Nɛl
Distal tibial intramεdulεri nεl (DTN) .
2025 mak CZMEDITECH in push insay di glob makɛt, wit Medlab Asia we de sav as springbɔd fɔ:
Kɔlabɔreshɔn: Patna wit big big glob ɔl ɛkspɛkt dɛm fɔ kɔ-divɛlɔp nɛks-jɛn ɔtpidik tɛnkɔlɔji dɛm.
Maket Penetreshɔn: Fɔ Target ASEAN in diman we de gro fɔ ay kwaliti, kɔst-ɛfɛktiv ɔspitul sɔlvishɔn.
R&D Investment: Fɔ mek di inovashɔn hab dɛn bɔku fɔ mek dɛn alaynɛd wit intanashɔnal standad dɛn.
CZMEDITECH in sakses na Medlab Asia 2025 de sho in strɔng kɔmitmɛnt fɔ ɔtpidik trauma sɔlvishɔn. Bay we dɛn de yuz dɛn kayn pletfɔm ya, di kɔmni de aim fɔ ridifayn ɔtpidik kia na di makit dɛn we de kam ɔp.
Prodakt dɛn we dɛn kin mek